BG
RDY icon

BlackRock Group’s Dr. Reddy's Laboratories RDY Stock Holding History

BlackRock Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$40.3M Sell
4,444,690
-62,330
-1% -$580K 0.02% 646
2016
Q3 		$41.8M Sell
4,507,020
-80,645
-2% -$770K 0.02% 629
2016
Q2 		$47M Sell
4,587,665
-2,266,780
-33% -$20.8M 0.02% 590
2016
Q1 		$62M Buy
6,854,445
+704,250
+11% +$6.29M 0.03% 519
2015
Q4 		$56.9M Buy
6,150,195
+1,054,420
+21% +$11.5M 0.03% 534
2015
Q3 		$65.1M Sell
5,095,775
-1,053,990
-17% -$13.1M 0.04% 488
2015
Q2 		$68M Sell
6,149,765
-373,180
-6% -$4.12M 0.04% 499
2015
Q1 		$74.5M Sell
6,522,945
-1,214,995
-16% -$12.9M 0.04% 490
2014
Q4 		$78.1M Sell
7,737,940
-325,190
-4% -$3.42M 0.04% 472
2014
Q3 		$84.7M Buy
8,063,130
+366,810
+5% +$3.45M 0.05% 424
2014
Q2 		$66.4M Sell
7,696,320
-778,110
-9% -$6.54M 0.04% 488
2014
Q1 		$74.4M Sell
8,474,430
-2,602,960
-23% -$22.6M 0.05% 439
2013
Q4 		$90.9M Buy
11,077,390
+50,260
+0.5% +$398K 0.06% 359
2013
Q3 		$83.3M Buy
11,027,130
+1,386,555
+14% +$10.1M 0.06% 389
2013
Q2 		$72.9M Buy
+9,640,575
New +$70.4M 0.06% 391

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's RDY Position: Q4 2016 in Review

BlackRock Group reduced its Dr. Reddy's Laboratories (RDY) stake by 1.4% in Q4 2016, selling an estimated $580K and leaving 4,444,690 shares worth $40.3M. The position accounts for 0.02% of the portfolio, ranked #646.

BlackRock Group first reported a position in RDY in Q2 2013 and has held it in 15 quarters since. The position peaked at $90.9M in Q4 2013. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

  • BlackRock Group held 4,444,690 shares of Dr. Reddy's Laboratories worth $40.3M as of Q4 2016.
  • BlackRock Group sold 62,330 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $580K.
  • Dr. Reddy's Laboratories made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #646 holding.
  • BlackRock Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Dr. Reddy's Laboratories position peaked at $90.9M in Q4 2013.
  • 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.